1021: The Significant Promise of Therapeutic Neuromodulation: Implications for Psychiatric Mental Health (PMH) Nursing
Speakers: Mary T. Rosedale, PhD, PMHNP-BC, NEA-BC; Donna J. Ecklesdafer, MSN, RN; Theresa C. Kormos, PMHCNS-BC; Michelle A. Freedland, RN-BC; Michelle M. Knapp, RN, BSN
Disclosures: Discussion of off-label uses will not take place during this presentation. The speaker Mary T. Rosedale has indicated a significant financial interest or other affiliation with Clinical Translation Research Institute. All other speakers and the activity planners have no conflicts of interest to disclose.
Session Length: 105 minutes
Target Audience: RN, APRN
Upon completion of this presentation, the participant will be able to:
1. Describe how neuromodulation aims to regulate neurotransmitters and downstream neurochemical cascades.
2. Examine the safety and efficacy of DBS, VNS, ECT, deep TMS, TMS and tDCS.
3. Identify opportunities for advancing the science of neuromodulation in PMH nursing and nursing research.
Continuing Nursing Education
1.75 contact hours. * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. We cannot award credit unless all steps are completed.
The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Wednesday, October 9, 2013
APNA 27th Annual Conference
Henry B. Gonzalez Convention Center
San Antonio, Texas
Release Date: January 29, 2014
The contact hours for this session expire: December 1, 2016